...
首页> 外文期刊>World Journal of Surgical Oncology >Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified
【24h】

Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified

机译:中国髓样乳腺癌患者的诊断和生存的临床病理特征:与浸润性导管癌的比较

获取原文
           

摘要

Background Few studies have addressed the biological features of medullary breast carcinoma (MBC) in the context of clinical outcomes. We sought to compare the baseline demographics, standard pathologic factors and long-term clinical outcomes between MBC and infiltrating ductal carcinoma-not otherwise specified (IDC-NOS) using a large database. Methods A total of 2,202 cases with pure IDC-NOS and 188 cases with typical MBC meeting the inclusion criteria were identified. The clinical and biological features, the overall survival (OS) and recurrence/metastasis-free survival (RFS) were compared for both groups. Results There were a higher proportion of patients diagnosed prior to 40 years of age in the MBC group compared to the IDC-NOS group. MBC cases demonstrated less aggressive tumor features such as lower tumor stage, smaller tumor size and a lower proportion of nodal involvement than IDC-NOS; however, immunohistochemical staining revealed that MBC displayed the triple-negative phenotype more often than IDC-NOS cases (40.4% versus 26.2%; P Conclusions MBC in Chinese women demonstrated less aggressive behavior and better prognosis than IDC-NOS. This favorable outcome was maintained after 10 years.
机译:背景技术很少有研究在临床结果的背景下探讨髓样乳腺癌(MBC)的生物学特征。我们试图使用大型数据库比较MBC和未另作说明的浸润性导管癌(IDC-NOS)之间的基线人口统计学,标准病理因素和长期临床结局。方法鉴定2202例纯IDC-NOS患者和188例典型MBC符合纳入标准的患者。比较两组的临床和生物学特征,总生存期(OS)和无复发/无转移生存期(RFS)。结果与IDC-NOS组相比,MBC组中40岁之前被诊断出的患者比例更高。与IDC-NOS相比,MBC病例显示出侵袭性较小的肿瘤特征,例如较低的肿瘤分期,较小的肿瘤大小和较少的淋巴结转移。然而,免疫组织化学染色显示,MBC较IDC-NOS病例显示三阴性表型的频率更高(40.4%对26.2%; P结论)中国女性MBC的攻击行为比IDC-NOS少,预后更好,这一良好的结果得以维持10年后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号